Crossref
Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective
Cardiovascular Science · 2025
DOI: 10.70322/cvs.2025.10010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Science, 2025. Verfasst von M. Olowofeso Abisola und 2 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abisola, M. O., Franki, E. M., & Natalya, S. Z. (2025). Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective. Cardiovascular Science. https://doi.org/10.70322/cvs.2025.10010
Vancouver
Abisola MO, Franki EM, Natalya SZ. Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective. Cardiovascular Science. 2025. doi:10.70322/cvs.2025.10010
BibTeX
@article{Abisola2025,
author = {Abisola, M. Olowofeso and Franki, E. Miller and Natalya, S. Zinkevich},
title = {Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective},
journal = {Cardiovascular Science},
year = {2025},
doi = {10.70322/cvs.2025.10010}
}
EUVIMED